What evidence emerged from the DCCT regarding intensive control of blood sugar for patients with type 1 diabetes and T2D?
The evidence that emerged from the DCCT (Diabetes Control and Complication Trial) regarding intensive control of blood sugar for patients with type 1 diabetes and T2D was that it delayed the onset or progression of nephropathy, retinopathy, and neuropathy, but was associated with increased risk for hypoglycemia.